Vectus Biosystems
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - non WAVectus Biosystems Limited (VBS) is a public company based at Julius Avenue, North Ryde, Sydney, Australia.
Vectus has developed potentially novel treatments for fibrosis and high blood pressure which include treatment for three of the largest diseases in the fibrotic franchise, namely heart, kidney and liver disease.
Contact Details
3-11 Primose Avenue, ROSEBERY NSW 2018
02 9662 4144
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 30/09/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1777th | Vectus Biosystems | -77% | -36% |
1743 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Vectus Biosystems | $1.1m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEW ROLE: Maurie Stang, Non-Executive Deputy Chair | 03 Nov 2020 |
| NEW ROLE: Ronald C Shnier, Non-Executive Director, Acting Chairman | 03 Nov 2020 |
| NEW ROLE: Peter Bush, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Susan Pond, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Karen A Duggan, Chief Executive Officer, Executive Director | 03 Nov 2020 |
| NEW ROLE: Robert Waring, Company Secretary | 03 Nov 2020 |
